Medeon Biodesign, Inc. (TPEX:6499)
85.00
-1.30 (-1.51%)
May 29, 2026, 1:30 PM CST
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 8.24 billion as of May 29, 2026. Its market cap has increased by 73.99% in one year.
Market Cap
8.24B
Enterprise Value
7.39B
Revenue
431.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.00
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 8.24B, an increase of 42.83%. That is a compound annual growth rate of 3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 8.24B | -5.47% |
| Dec 31, 2025 | 8.72B | 138.60% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Visco Vision | 12.16B |
| Vizionfocus | 11.56B |
| Bioteque | 7.93B |
| Pacific Hospital Supply | 5.75B |
| Formosa Optical Technology | 5.66B |
| St.Shine Optical | 4.74B |
| SciVision Biotech | 3.94B |
| Bionime | 3.84B |